Satellos Bioscience Inc. (TSX:MSCL)
10.41
+0.57 (5.79%)
Apr 28, 2026, 3:59 PM EST
Satellos Bioscience Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
216.85M CAD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSatellos Bioscience News
- 19 days ago - Satellos to Present at the Bloom Burton & Co. Healthcare Investor Conference - GlobeNewsWire
- 4 weeks ago - MSLE: Analyst Sets $11 Price Target for Satellos Bioscience - GuruFocus
- 4 weeks ago - MSLE: HC Wainwright & Co. Raises Price Target for Satellos Bioscience | MSLE Stock News - GuruFocus
- 4 weeks ago - Satellos Bioscience: 2025 Financial Performance - AlphaStreet
- 4 weeks ago - Satellos Reports 2025 Financial Results and Highlights Recent Company Progress - Benzinga
- 4 weeks ago - Satellos Reports 2025 Financial Results and Highlights Recent Company Progress - GlobeNewsWire
- 2 months ago - Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference - Business Wire
- 2 months ago - Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy - Business Wire